XML 22 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Non-controlling Interest
Beginning Balance (in shares) at Dec. 31, 2021   81,210,626      
Beginning Balance at Dec. 31, 2021 $ 281,873 $ 812 $ 278,500 $ 622 $ 1,939
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,399)     (5,622) (777)
Distributions and dividends on common stock (16,250)   (16,250)    
Restricted stock grant (in shares)   65,000      
Restricted stock grants 0 $ 1 (1)    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (394,604)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (1,626) $ (4) (1,622)    
Stock-based compensation 11,138   11,138    
Net transfers from non-controlling interest 375       375
Other 1,346   1,346    
Ending Balance (in shares) at Dec. 31, 2022   80,881,022      
Ending Balance at Dec. 31, 2022 270,457 $ 809 273,111 (5,000) 1,537
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (43,166)     (42,552) (614)
Distributions and dividends on common stock (in shares)   (372)      
Distributions and dividends on common stock (4,222)   (4,222)    
Restricted stock grant (in shares)   3,610,000      
Restricted stock grants 0 $ 36 (36)    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (785,842)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (1,990) $ (8) (1,982)    
Effect of stock dividend (in shares)   4,220,604      
Effect of stock dividend 0 $ 42 (42)    
Stock-based compensation $ 13,075   13,075    
Ending Balance (in shares) at Dec. 31, 2023 87,925,412 87,925,412      
Ending Balance at Dec. 31, 2023 $ 234,154 $ 879 279,904 (47,552) 923
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (77,002)     (76,316) (686)
Restricted stock grant (in shares)   5,982,023      
Restricted stock grants 0 $ 60 (60)    
Restricted stock grant cancelled (in shares)   (4,365,500)      
Restricted stock grant canceled 0 $ (44) 44    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (688,785)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (1,352) $ (6) (1,346)    
Stock-based compensation 6,574   6,574    
Other $ 51   51    
Ending Balance (in shares) at Dec. 31, 2024 88,853,150 88,853,150      
Ending Balance at Dec. 31, 2024 $ 162,425 $ 889 $ 285,167 $ (123,868) $ 237